Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
In a whirlwind seven-month period in 2022, Bristol-Myers Squibb received FDA approval for three new…
A study of misophonia patients found that about 65% had a diagnosis of at least…
Important points: A major German manufacturer has sent lawyers and lobbyists in and around Washington,…
WASHINGTON (AP) – A Virginia boater is suing a Washington water utility company for negligence…
Issues at the former Catalent plant, now owned by Novo Nordisk, derailed another FDA application,…
In a study of adults with advanced prostate cancer taking androgen receptor pathway inhibitors and…
Ipsen is halting sales of its cancer drug Tazveric, which it acquired through its acquisition…
As the days begin to get longer again, Dr. Christine Bloom’s phone rings frequently. That’s…
In recent research, sleep research journal It suggests that people who frequently experience lucid dreams…
Kenya was shocked when she was diagnosed with multiple sclerosis (MS). Active and busy with…